Cargando…
An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
The future of treating inherited and acquired genetic diseases will be defined by our ability to introduce transgenes into cells and restore normal physiology. Here we describe an autogenous transgene regulatory system (ARES), based on the bacterial lac repressor, and demonstrate its utility for con...
Autores principales: | Sochor, Matthew A., Vasireddy, Vidyullatha, Drivas, Theodore G., Wojno, Adam, Doung, Thu, Shpylchak, Ivan, Bennicelli, Jeannette, Chung, Daniel, Bennett, Jean, Lewis, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656984/ https://www.ncbi.nlm.nih.gov/pubmed/26597678 http://dx.doi.org/10.1038/srep17105 |
Ejemplares similares
-
Author Correction: An Autogenously Regulated Expression System for Gene Therapeutic Ocular Applications
por: Sochor, Matthew A., et al.
Publicado: (2018) -
Treatment Potential for LCA5-Associated Leber Congenital Amaurosis
por: Uyhazi, Katherine E., et al.
Publicado: (2020) -
Stem cells set their sights on retinitis pigmentosa
por: Bennicelli, Jeannette L, et al.
Publicado: (2013) -
AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models
por: Vasireddy, Vidyullatha, et al.
Publicado: (2013) -
Correction: AAV-Mediated Gene Therapy for Choroideremia: Preclinical Studies in Personalized Models
por: Vasireddy, Vidyullatha, et al.
Publicado: (2015)